Search Results - "Johansen Taber Katherine A"

Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen by Beauchamp, Kyle A., Johansen Taber, Katherine A., Muzzey, Dale

“…Carrier screening identifies couples at high risk for conceiving offspring affected with serious heritable conditions. Minimal guidelines recommend offering…”
Get full text

The promise and challenges of next-generation genome sequencing for clinical care by Johansen Taber, Katherine A, Dickinson, Barry D, Wilson, Modena

“…With increased speed and decreased costs, next-generation gene sequencing has the potential to improve medical care by making possible widespread evaluation of…”
Get more information

Strategies for Improving Access to Hereditary Cancer Testing: Recommendations from Stakeholders by Ready, Kaylene, Johansen Taber, Katherine A., Bonhomme, Natasha, Lichtenfeld, J. Leonard

Get full text

Clinical utility of expanded carrier screening: results-guided actionability and outcomes by Johansen Taber, Katherine A., Beauchamp, Kyle A., Lazarin, Gabriel A., Muzzey, Dale, Arjunan, Aishwarya, Goldberg, James D.

“…Purpose Expanded carrier screening (ECS) informs couples of their risk of having offspring affected by certain genetic conditions. Limited data exists…”
Get full text

Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen by Beauchamp, Kyle A., Johansen Taber, Katherine A., Muzzey, Dale

Get full text

Sequencing as a first-line methodology for cystic fibrosis carrier screening by Beauchamp, Kyle A., Johansen Taber, Katherine A., Grauman, Peter V., Spurka, Lindsay, Lim-Harashima, Jeraldine, Svenson, Ashley, Goldberg, James D., Muzzey, Dale

“…Purpose Medical society guidelines recommend offering genotyping-based cystic fibrosis (CF) carrier screening to pregnant women or women considering pregnancy…”
Get full text

Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties by Johansen Taber, Katherine A, Dickinson, Barry D

“…The use of pharmacogenomic testing in the clinical setting has the potential to improve the safety and effectiveness of drug therapy, yet studies have revealed…”
Get full text

What works in genomics education: outcomes of an evidenced-based instructional model for community-based physicians by Reed, E. Kate, Johansen Taber, Katherine A., Ingram Nissen, Therese, Schott, Suzanna, Dowling, Lynn O., O'Leary, James C., Scott, Joan A.

“…Education of practicing health professionals is likely to be one factor that will speed appropriate integration of genomics into routine clinical practice. Yet…”
Get full text

Male breast cancer: Risk factors, diagnosis, and management (Review) by JOHANSEN TABER, Katherine A, MORISY, Lee R, OSBAHR, Albert J, DICKINSON, Barry D

“…Male breast cancer (MBC) is extremely rare, with an incidence in the general US population of <1%. It tends to be diagnosed at later stages than breast cancer…”
Get full text

Challenges and Opportunities for Genomics Education: Insights from an Institute of Medicine Roundtable Activity by Dougherty, Michael J, Wicklund, Catherine, Johansen Taber, Katherine A

“…Despite the growing availability of genomic tools for clinical care, many health care providers experience gaps in genomics knowledge and skills that serve as…”
Get full text

Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening by Beauchamp, Kyle A., Taber, Katherine A. Johansen, Grauman, Peter V., Spurka, Lindsay, Lim-Harashima, Jeraldine, Svenson, Ashley, Goldberg, James D., Muzzey, Dale

“…The original version of this Article contained an error in Figure 3. Specifically, the result “3 (67%) TOP” should read “2 (67%) TOP.” This has now been…”
Get full text

Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes by Johansen Taber, Katherine A, Dickinson, Barry D

“…Type 2 diabetes (T2D) is a common and serious disorder and is a significant risk factor for the development of cardiovascular disease, neuropathy, nephropathy,…”
Get full text

Clinical Utility of Expanded Carrier Screening: Results-Guided Actionability and Outcomes by Johansen Taber, Katherine A, Beauchamp, Kyle A, Lazarin, Gabriel A, Muzzey, Dale, Arjunan, Aishwarya, Goldberg, James D

“…(Abstracted from Genet Med 2019;21(5):1041–1048)One in 300 pregnancies is impacted by a recessive or X-linked condition. Universal screening is recommended by…”
Get full text

Sequencing as a first-line methodology for cystic fibrosiscarrier screening by Beauchamp, Kyle A, Johansen Taber Katherine A, Grauman, Peter V, Spurka Lindsay, Lim-Harashima Jeraldine, Svenson, Ashley, Goldberg, James D, Muzzey Dale

“…PurposeMedical society guidelines recommend offering genotyping-based cystic fibrosis (CF) carrier screening to pregnant women or women considering pregnancy…”
Get full text